Transforming pharma R&D with a scientist-centric approach to AI & automation
pharmaphorum
JUNE 16, 2021
Borrowing from the Computer-Aided Design and Manufacturing (CAD/CAM) approaches in the semiconductor industry, a similar concept, called Computer-Aided Biology (CAB), can be applied to the life sciences. Deloitte anticipates that the next five years could see AI dramatically accelerating the drug discovery process. About the author.
Let's personalize your content